Comparación del efecto terapéutico de células madres de líquido amniótico y plasma rico en plaquetas contra mastitis subclínica en ganado lechero

Abstract

In this present study, we address the issue of subclinical mastitis in dairy cattle, a common condition that poses significant challenges in milk production. The main objective of the research is to compare the therapeutic effect of amniotic fluid-derived stem cells and platelet-rich plasma, with a focus on improving mammary health. To achieve this purpose, an experimental study was conducted involving dairy cows divided into three groups: a control group treated with antibiotic based on antibiogram, another group treated with amniotic fluid, and a third group with platelet-rich plasma. The methodology involved intramammary administration of the respective treatments, followed by the assessment of key parameters such as somatic cell count and CFU. The results showed no significant difference; however, regarding somatic cell count, T1 was 1,284,453.13, while in the T2 treated group, it was 381,288.75, and T3 recorded 1,121,625.00. In terms of CFU, T1 presented 24.31, while T2 showed 12.38, and the T3 group registered 7.25. These findings underscore the effectiveness of both therapies in reducing subclinical mastitis in dairy cattle. In conclusion, the application of amniotic fluid-derived stem cells and platelet-rich plasma emerges as promising alternatives for enhancing mammary health in dairy cattle, providing new perspectives for managing this condition in the dairy industry. Keywords: Subclinical mastitis, Stem cells, Platelet-rich plasma, Dairy cattle